Paper7908520
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate.
Hoffman GS and 5 others. Arthritis Rheum, 1994. Cited by 272 papers, by iCite.
Cite this record
ConductScience Library. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Papers, record 7908520. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7908520
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucocorticoids | Major topic |
| Methotrexate | Major topic |
| Takayasu Arteritis | Major topic |
| Adolescent | |
| Adult | |
| Drug Administration Schedule | |
| Drug Resistance | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Recurrence | |
| Remission Induction |
Source PubMed
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 272 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42770035 | Takayasu Arteritis in a 15-Year-Old Male Presenting with Constitutional Symptoms and Upper Limb Pulse Deficit: A Case Report a Resource-Limited Settings. | Int Med Case Rep J | 2026 | https://conductscience.org/library/papers/42770035 | PubMed |
| 42081084 | Large Vessel Vasculitis: Recent Advances in Pathophysiology and Targeted Therapies. | Drugs | 2026 | https://conductscience.org/library/papers/42081084 | PubMed |
| 41587271 | Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification. | Circulation | 2026 | https://conductscience.org/library/papers/41587271 | PubMed |
| 40535368 | A 50-Year Delay in the Diagnosis of Takayasu Arteritis: Clinical Presentation and Therapeutic Insights. | Cureus | 2025 | https://conductscience.org/library/papers/40535368 | PubMed |
| 39377926 | Cerebrovascular implications of takayasu arteritis: a review. | Neuroradiology | 2025 | https://conductscience.org/library/papers/39377926 | PubMed |
| 39319180 | Severe aortic valve regurgitation in patient with Takayasu arteritis: a case report. | Eur Heart J Case Rep | 2024 | https://conductscience.org/library/papers/39319180 | PubMed |
| 39077599 | Clinical Features of Aortitis with Gastrointestinal Involvement. | Rev Cardiovasc Med | 2022 | https://conductscience.org/library/papers/39077599 | PubMed |
| 38933629 | Unravelling a Triad: A Rare Case of Takayasu Arteritis, Hashimoto's Thyroiditis, and Psoriasis in a Young Female With Heart Failure. | Cureus | 2024 | https://conductscience.org/library/papers/38933629 | PubMed |
| 38158224 | Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update. | Stroke Vasc Neurol | 2023 | https://conductscience.org/library/papers/38158224 | PubMed |
| 38125643 | Advances and challenges in management of large vessel vasculitis. | Rheumatol Immunol Res | 2023 | https://conductscience.org/library/papers/38125643 | PubMed |
| 37321669 | Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study. | RMD Open | 2023 | https://conductscience.org/library/papers/37321669 | PubMed |
| 36045929 | Advances in Takayasu arteritis: An Asia Pacific perspective. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36045929 | PubMed |
| 35601856 | Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin? | Saudi J Ophthalmol | 2021 | https://conductscience.org/library/papers/35601856 | PubMed |
| 35096902 | Novel Therapies in Takayasu Arteritis. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/35096902 | PubMed |
| 34685390 | Takayasu's Arteritis Diagnosed in an Adolescent Patient with Crohn's Disease: Management of Biologicals. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34685390 | PubMed |
| 34671607 | Single-Cell RNA Sequencing Revealed CD14+ Monocytes Increased in Patients With Takayasu's Arteritis Requiring Surgical Management. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34671607 | PubMed |
| 34435143 | Non-specific aortoarteritis (NSAA) in children: a prospective observational study. | BMJ Paediatr Open | 2021 | https://conductscience.org/library/papers/34435143 | PubMed |
| 34317327 | Takayasu Arteritis With Extensive Cardiovascular, Neurovascular, and Mesenteric Involvement. | JACC Case Rep | 2020 | https://conductscience.org/library/papers/34317327 | PubMed |
| 33932173 | Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis-a systematic review and meta-analysis. | Clin Rheumatol | 2021 | https://conductscience.org/library/papers/33932173 | PubMed |
| 33646393 | A hypertensive girl with failure to thrive accompanied by gastrointestinal symptoms: Answers. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/33646393 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7908520
GET https://conductscience.org/api/papers/v1/7908520/cited_by?page=2